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Haji Bahadar1 and Mohammad Abdollahi1,2*We would like to draw the attention of the readers to
the inappropriate use of term “cytotoxic” as a substitute
for “antineoplastic”. This can be noticed in numerous
scientific articles, especially those reporting the anticancer
properties of certain chemical compounds. For example,
there are published studies reporting the anticancer
activity of certain drugs/chemicals and the authors have
assessed the anticancer activities of some novel drugs
against certain target cancers. These investigations have
repeatedly involved the term “cytotoxic” instead of
“antineoplastic”. For instance, recently a report has been
published in DARU by Vosough et al. [1] about the
anticancer activities of some compounds. In this study,
the derivatives of nonsteroidal aromatase inhibitors
(triazole analogues) have been synthesized. Then, the
newly synthesized derivatives were assessed for anticancer
activity against breast cancer cell lines and the results
showed that these newly synthesized compounds possess
potent cytotoxic activity. Similarly, there are numerous
other research reports published either in DARU or else-
where. These authors also have reported the anticancer
activities of different compounds against various cancer
cell lines [2-4]. Nonetheless, these authors have assessed
the cytotoxicity as a measure of anti-neoplastic potential
of certain drugs, but, reporting the effect as “cytotoxic”
instead of either “anticancer” or “antineoplastic” might
reduce the interest of readers.
Literally cytotoxic refers to “toxic to living cells” while,
antineoplastic means inhibiting or preventing the devel-
opment and spread of neoplasms. For drugs that control
or kill only neoplastic cells, the proper term that could
describe this inherent activity of drugs is known as anti-
neoplastic or anticancer activity. Moreover, the physiology
of a normal cell is entirely dissimilar to that of cancerous
cells or neoplasms, having an excessive quantity of free
radicals and subsequent oxidative stress [5,6]. Cytotoxicity* Correspondence: Mohammad@TUMS.Ac.Ir
1Pharmaceutical Sciences Research Center, International Campus, Tehran
University of Medical Sciences, Tehran, Iran
2Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
© 2015 Bahadar and Abdollahi; licensee BioM
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.is a general term used in toxicological studies describing
the effect of particular toxins on cell viability [7]. In that
respect, there are many compounds that are cytotoxic but
not antineoplastic [8]. About anticancer drugs, data can
be gathered using cytotoxicity test methods, but that
necessarily be described as the antineoplastic or antican-
cer activity of that particular drug or agent, rather than
stating cytotoxicity of anticancer drugs. Because the term
cytotoxicity is an umbrella term involving also other
toxins which reduce normal cell viability. In simpler
words, we may say that a drug with antineoplastic activity
possess cytotoxicity. But any cytotoxic agent does not
necessarily possess antineoplastic characteristics.
At the end, we are of the opinion that great care must
be exercised while using the term cytotoxicity as an al-
ternative to antineoplastic activity, particularly mention-
ing the activity of anticancer agents. Also, the National
Library of Medicine–Medical Subject Headings (MeSH)
http://www.nlm.nih.gov/mesh/MBrowser.html does not
suggest the term cytotoxic as a substitute for antineoplas-
tic, but the opposite could easily be seen. Furthermore,
MeSH is a very comprehensive controlled scientific
terminology helping in proper indexing of the scientific
article and books.
Received: 12 February 2015 Accepted: 14 February 2015References
1. Vosooghi M, Firoozpour L, Rodaki A, Pordeli M, Safavi M, Ardestani SK, et al.
Design, synthesis, docking study and cytotoxic activity evaluation of some
novel letrozole analogs. Daru. 2014;22:83.
2. De Vasconcelos A, Campos VF, Nedel F, Seixas FK, Dellagostin OA, Smith KR,
et al. Cytotoxic and apoptotic effects of chalcone derivatives of 2-acetyl
thiophene on human colon adenocarcinoma cells. Cell Biochem Funct.
2013;31:289–97.
3. Alipour E, Mousavi Z, Safaei Z, Pordeli M, Safavi M, Firoozpour L, et al.
Synthesis and cytotoxic evaluation of some new [1,3]dioxolo[4,5-g]
chromen-8-one derivatives. Daru. 2014;22:41.
4. Haghighi F, Matin MM, Bahrami AR, Iranshahi M, Rassouli FB, Haghighitalab
A. The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via in-
duction of apoptosis and cell cycle arrest in G2/M stage. Daru. 2014;22:3.
5. Abdollahi M, Shetab-Boushehri SV. Is it right to look for anti-cancer drugs
amongst compounds having antioxidant effect. Daru. 2012;20:61.ed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Bahadar and Abdollahi DARU Journal of Pharmaceutical Sciences  (2015) 23:17 Page 2 of 26. Shetab-Boushehri SV, Abdollahi M. Current concerns on the validity of
in vitro models that use transformed neoplastic cells in pharmacology and
toxicology. Int J Pharmacol. 2012;8:594–5.
7. Riss TL, Moravec RA, Niles AL. Cytotoxicity testing: measuring viable cells,
dead cells, and detecting mechanism of cell death. Methods Mol Biol.
2011;740:103–14.
8. Saeidnia S, Abdollahi M. Antioxidants: Friends or foe in prevention or
treatment of cancer: The debate of the century. Toxicol Appl Pharmacol.
2013;271:49–63.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
